uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Total Current Liabilities (2015 - 2026)

uniQure (QURE) posted quarterly Total Current Liabilities of $83.3 million for Q2 2026, up 103.63% year-over-year from $40.9 million in Q2 2025, and up 40.79% quarter-over-quarter from $59.2 million in Q1 2026.

Analysis

uniQure (QURE) Total Current Liabilities (2015 - 2026) Analysis & Trends

uniQure's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $83.3 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 103.63% year-over-year to $83.3 million; the TTM figure through Jun 2026 stood at $83.3 million (up 103.63% YoY), while the FY2025 annual figure was $62.9 million, up 57.09% from the prior year.
  • Total Current Liabilities for Q2 2026 stood at $83.3 million, up from $59.2 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $100.6 million in Q3 2025, with the low at $36.3 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $65.2 million (2022), against an average of $63.8 million.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 106.51% in 2022, then sank 49.14% in 2025.
  • uniQure's Total Current Liabilities stood at $75.9 million in 2022, then declined by 2.96% to $73.7 million in 2023, then sank by 45.64% to $40.1 million in 2024, then jumped by 57.09% to $62.9 million in 2025, then soared by 32.46% to $83.3 million in 2026.
  • Business Quant data shows QURE's Total Current Liabilities at $83.3 million in Q2 2026, $59.2 million in Q1 2026, and $62.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 83.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.35 Mn
Mar 31, 2026 59.20 Mn
Dec 31, 2025 62.92 Mn
Sep 30, 2025 100.63 Mn
Jun 30, 2025 40.93 Mn
Mar 31, 2025 36.31 Mn
Dec 31, 2024 40.05 Mn
Sep 30, 2024 71.27 Mn
Jun 30, 2024 80.47 Mn
Mar 31, 2024 63.47 Mn
Dec 31, 2023 73.68 Mn
Sep 30, 2023 68.61 Mn
Jun 30, 2023 68.36 Mn
Mar 31, 2023 66.34 Mn
Dec 31, 2022 75.92 Mn
Sep 30, 2022 63.97 Mn
Jun 30, 2022 48.26 Mn
Mar 31, 2022 44.70 Mn
Dec 31, 2021 36.76 Mn
Sep 30, 2021 41.92 Mn